The global Adoptive Cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Adoptive Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adoptive Cell Therapy.

Report Scope

The Adoptive Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adoptive Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Adoptive Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Adoptive Cell Therapy Market Report

Report Metric	Details
Report Name	Adoptive Cell Therapy Market
CAGR	5%
Segment by Type	CAR-T TCR-T NK TIL
Segment by Application	Lymphoma Leukemia
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation, Regeneus, Anhui Anke Biotechnology, Cellectis, NantKwest, SorrentoTherapeutics, Bellicum
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adoptive Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Adoptive Cell Therapy Market report?

Ans: The main players in the Adoptive Cell Therapy Market are Novartis, Juno, Kite, Adaptimmune, Fibrocell, Lineage Cell Therapeutics, BioTime, Vericel Corporation, Regeneus, Anhui Anke Biotechnology, Cellectis, NantKwest, SorrentoTherapeutics, Bellicum

What are the Application segmentation covered in the Adoptive Cell Therapy Market report?

Ans: The Applications covered in the Adoptive Cell Therapy Market report are Lymphoma, Leukemia

What are the Type segmentation covered in the Adoptive Cell Therapy Market report?

Ans: The Types covered in the Adoptive Cell Therapy Market report are CAR-T, TCR-T, NK, TIL

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 CAR-T

1.2.3 TCR-T

1.2.4 NK

1.2.5 TIL

1.3 Market by Application

1.3.1 Global Adoptive Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Lymphoma

1.3.3 Leukemia

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Adoptive Cell Therapy Market Perspective (2019-2030)

2.2 Adoptive Cell Therapy Growth Trends by Region

2.2.1 Global Adoptive Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Adoptive Cell Therapy Historic Market Size by Region (2019-2024)

2.2.3 Adoptive Cell Therapy Forecasted Market Size by Region (2025-2030)

2.3 Adoptive Cell Therapy Market Dynamics

2.3.1 Adoptive Cell Therapy Industry Trends

2.3.2 Adoptive Cell Therapy Market Drivers

2.3.3 Adoptive Cell Therapy Market Challenges

2.3.4 Adoptive Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Adoptive Cell Therapy Players by Revenue

3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2019-2024)

3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue

3.4 Global Adoptive Cell Therapy Market Concentration Ratio

3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2023

3.5 Adoptive Cell Therapy Key Players Head office and Area Served

3.6 Key Players Adoptive Cell Therapy Product Solution and Service

3.7 Date of Enter into Adoptive Cell Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Adoptive Cell Therapy Breakdown Data by Type

4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2019-2024)

4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2025-2030)

5 Adoptive Cell Therapy Breakdown Data by Application

5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2019-2024)

5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Adoptive Cell Therapy Market Size (2019-2030)

6.2 North America Adoptive Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Adoptive Cell Therapy Market Size by Country (2019-2024)

6.4 North America Adoptive Cell Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Adoptive Cell Therapy Market Size (2019-2030)

7.2 Europe Adoptive Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Adoptive Cell Therapy Market Size by Country (2019-2024)

7.4 Europe Adoptive Cell Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Adoptive Cell Therapy Market Size (2019-2030)

8.2 Asia-Pacific Adoptive Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Adoptive Cell Therapy Market Size (2019-2030)

9.2 Latin America Adoptive Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Adoptive Cell Therapy Market Size by Country (2019-2024)

9.4 Latin America Adoptive Cell Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Adoptive Cell Therapy Market Size (2019-2030)

10.2 Middle East & Africa Adoptive Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Detail

11.1.2 Novartis Business Overview

11.1.3 Novartis Adoptive Cell Therapy Introduction

11.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2019-2024)

11.1.5 Novartis Recent Development

11.2 Juno

11.2.1 Juno Company Detail

11.2.2 Juno Business Overview

11.2.3 Juno Adoptive Cell Therapy Introduction

11.2.4 Juno Revenue in Adoptive Cell Therapy Business (2019-2024)

11.2.5 Juno Recent Development

11.3 Kite

11.3.1 Kite Company Detail

11.3.2 Kite Business Overview

11.3.3 Kite Adoptive Cell Therapy Introduction

11.3.4 Kite Revenue in Adoptive Cell Therapy Business (2019-2024)

11.3.5 Kite Recent Development

11.4 Adaptimmune

11.4.1 Adaptimmune Company Detail

11.4.2 Adaptimmune Business Overview

11.4.3 Adaptimmune Adoptive Cell Therapy Introduction

11.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2019-2024)

11.4.5 Adaptimmune Recent Development

11.5 Fibrocell

11.5.1 Fibrocell Company Detail

11.5.2 Fibrocell Business Overview

11.5.3 Fibrocell Adoptive Cell Therapy Introduction

11.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2019-2024)

11.5.5 Fibrocell Recent Development

11.6 Lineage Cell Therapeutics

11.6.1 Lineage Cell Therapeutics Company Detail

11.6.2 Lineage Cell Therapeutics Business Overview

11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction

11.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2019-2024)

11.6.5 Lineage Cell Therapeutics Recent Development

11.7 BioTime

11.7.1 BioTime Company Detail

11.7.2 BioTime Business Overview

11.7.3 BioTime Adoptive Cell Therapy Introduction

11.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2019-2024)

11.7.5 BioTime Recent Development

11.8 Vericel Corporation

11.8.1 Vericel Corporation Company Detail

11.8.2 Vericel Corporation Business Overview

11.8.3 Vericel Corporation Adoptive Cell Therapy Introduction

11.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2019-2024)

11.8.5 Vericel Corporation Recent Development

11.9 Regeneus

11.9.1 Regeneus Company Detail

11.9.2 Regeneus Business Overview

11.9.3 Regeneus Adoptive Cell Therapy Introduction

11.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2019-2024)

11.9.5 Regeneus Recent Development

11.10 Anhui Anke Biotechnology

11.10.1 Anhui Anke Biotechnology Company Detail

11.10.2 Anhui Anke Biotechnology Business Overview

11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction

11.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2019-2024)

11.10.5 Anhui Anke Biotechnology Recent Development

11.11 Cellectis

11.11.1 Cellectis Company Detail

11.11.2 Cellectis Business Overview

11.11.3 Cellectis Adoptive Cell Therapy Introduction

11.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2019-2024)

11.11.5 Cellectis Recent Development

11.12 NantKwest

11.12.1 NantKwest Company Detail

11.12.2 NantKwest Business Overview

11.12.3 NantKwest Adoptive Cell Therapy Introduction

11.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2019-2024)

11.12.5 NantKwest Recent Development

11.13 SorrentoTherapeutics

11.13.1 SorrentoTherapeutics Company Detail

11.13.2 SorrentoTherapeutics Business Overview

11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction

11.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2019-2024)

11.13.5 SorrentoTherapeutics Recent Development

11.14 Bellicum

11.14.1 Bellicum Company Detail

11.14.2 Bellicum Business Overview

11.14.3 Bellicum Adoptive Cell Therapy Introduction

11.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2019-2024)

11.14.5 Bellicum Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Lineage Cell Therapeutics

BioTime

Vericel Corporation

Regeneus

Anhui Anke Biotechnology

List of Tables

Table 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of CAR-T

Table 3. Key Players of TCR-T

Table 4. Key Players of NK

Table 5. Key Players of TIL

Table 6. Global Adoptive Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Adoptive Cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Adoptive Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Adoptive Cell Therapy Market Share by Region (2019-2024)

Table 10. Global Adoptive Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Adoptive Cell Therapy Market Share by Region (2025-2030)

Table 12. Adoptive Cell Therapy Market Trends

Table 13. Adoptive Cell Therapy Market Drivers

Table 14. Adoptive Cell Therapy Market Challenges

Table 15. Adoptive Cell Therapy Market Restraints

Table 16. Global Adoptive Cell Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Adoptive Cell Therapy Market Share by Players (2019-2024)

Table 18. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2023)

Table 19. Ranking of Global Top Adoptive Cell Therapy Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Adoptive Cell Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Adoptive Cell Therapy Product Solution and Service

Table 23. Date of Enter into Adoptive Cell Therapy Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Adoptive Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Adoptive Cell Therapy Revenue Market Share by Type (2019-2024)

Table 27. Global Adoptive Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Adoptive Cell Therapy Revenue Market Share by Type (2025-2030)

Table 29. Global Adoptive Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Adoptive Cell Therapy Revenue Market Share by Application (2019-2024)

Table 31. Global Adoptive Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Adoptive Cell Therapy Revenue Market Share by Application (2025-2030)

Table 33. North America Adoptive Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Adoptive Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Adoptive Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Adoptive Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Adoptive Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Adoptive Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Adoptive Cell Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Adoptive Cell Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Adoptive Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Adoptive Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Adoptive Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Adoptive Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Adoptive Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 48. Novartis Company Detail

Table 49. Novartis Business Overview

Table 50. Novartis Adoptive Cell Therapy Product

Table 51. Novartis Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 52. Novartis Recent Development

Table 53. Juno Company Detail

Table 54. Juno Business Overview

Table 55. Juno Adoptive Cell Therapy Product

Table 56. Juno Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 57. Juno Recent Development

Table 58. Kite Company Detail

Table 59. Kite Business Overview

Table 60. Kite Adoptive Cell Therapy Product

Table 61. Kite Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 62. Kite Recent Development

Table 63. Adaptimmune Company Detail

Table 64. Adaptimmune Business Overview

Table 65. Adaptimmune Adoptive Cell Therapy Product

Table 66. Adaptimmune Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 67. Adaptimmune Recent Development

Table 68. Fibrocell Company Detail

Table 69. Fibrocell Business Overview

Table 70. Fibrocell Adoptive Cell Therapy Product

Table 71. Fibrocell Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 72. Fibrocell Recent Development

Table 73. Lineage Cell Therapeutics Company Detail

Table 74. Lineage Cell Therapeutics Business Overview

Table 75. Lineage Cell Therapeutics Adoptive Cell Therapy Product

Table 76. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 77. Lineage Cell Therapeutics Recent Development

Table 78. BioTime Company Detail

Table 79. BioTime Business Overview

Table 80. BioTime Adoptive Cell Therapy Product

Table 81. BioTime Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 82. BioTime Recent Development

Table 83. Vericel Corporation Company Detail

Table 84. Vericel Corporation Business Overview

Table 85. Vericel Corporation Adoptive Cell Therapy Product

Table 86. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 87. Vericel Corporation Recent Development

Table 88. Regeneus Company Detail

Table 89. Regeneus Business Overview

Table 90. Regeneus Adoptive Cell Therapy Product

Table 91. Regeneus Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 92. Regeneus Recent Development

Table 93. Anhui Anke Biotechnology Company Detail

Table 94. Anhui Anke Biotechnology Business Overview

Table 95. Anhui Anke Biotechnology Adoptive Cell Therapy Product

Table 96. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 97. Anhui Anke Biotechnology Recent Development

Table 98. Cellectis Company Detail

Table 99. Cellectis Business Overview

Table 100. Cellectis Adoptive Cell Therapy Product

Table 101. Cellectis Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 102. Cellectis Recent Development

Table 103. NantKwest Company Detail

Table 104. NantKwest Business Overview

Table 105. NantKwest Adoptive Cell Therapy Product

Table 106. NantKwest Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 107. NantKwest Recent Development

Table 108. SorrentoTherapeutics Company Detail

Table 109. SorrentoTherapeutics Business Overview

Table 110. SorrentoTherapeutics Adoptive Cell Therapy Product

Table 111. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 112. SorrentoTherapeutics Recent Development

Table 113. Bellicum Company Detail

Table 114. Bellicum Business Overview

Table 115. Bellicum Adoptive Cell Therapy Product

Table 116. Bellicum Revenue in Adoptive Cell Therapy Business (2019-2024) & (US$ Million)

Table 117. Bellicum Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Adoptive Cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Adoptive Cell Therapy Market Share by Type: 2023 VS 2030

Figure 3. CAR-T Features

Figure 4. TCR-T Features

Figure 5. NK Features

Figure 6. TIL Features

Figure 7. Global Adoptive Cell Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Adoptive Cell Therapy Market Share by Application: 2023 VS 2030

Figure 9. Lymphoma Case Studies

Figure 10. Leukemia Case Studies

Figure 11. Adoptive Cell Therapy Report Years Considered

Figure 12. Global Adoptive Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Adoptive Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Adoptive Cell Therapy Market Share by Region: 2023 VS 2030

Figure 15. Global Adoptive Cell Therapy Market Share by Players in 2023

Figure 16. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2023

Figure 18. North America Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Adoptive Cell Therapy Market Share by Country (2019-2030)

Figure 20. United States Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Adoptive Cell Therapy Market Share by Country (2019-2030)

Figure 24. Germany Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Adoptive Cell Therapy Market Share by Region (2019-2030)

Figure 32. China Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Adoptive Cell Therapy Market Share by Country (2019-2030)

Figure 40. Mexico Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Adoptive Cell Therapy Market Share by Country (2019-2030)

Figure 44. Turkey Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Adoptive Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 47. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 48. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 49. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 50. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 51. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 52. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 53. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 54. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 55. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 56. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 57. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 58. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 59. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Nocturia Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39M10215

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Medicine Treat BPH Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33F12613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Neurorehabilitation Gaming Systems Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E10017

Sun Apr 28 00:00:00 UTC 2024

Add to Cart

Global Addison's Disease Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-15W2944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions